No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Eusol Biotech Co.,Ltd. is a biopharmaceutical firm primarily dedicated to the discovery and advancement of innovative biotechnological treatments for various sleep-related conditions. Its current development portfolio showcases two key candidates: ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) designed to restore and repair neuronal function; and SM-1, a singular capsule formulation that combines three commercially available sedative medications. The company commenced operations in 1994 and maintains its principal offices in Taipei, Taiwan.
www.eusol-biotech.comNo one on the platform currently holds 6652.TWO.
No tracked institution reports a position in 6652.TWO as of their last filing.
No one on the platform has traded 6652.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 6652.TWOEusol Biotech Co.,Ltd. | $1.96 | +0.00% | $269M | — |
| 3118.TWOLevel Biotechnology Inc. | $31.40 | -0.79% | $1.0B | — |
| 4192.TWOSynCore Biotechnology Co.,Ltd | $19.45 | +3.18% | $684M | — |
| 4198.TWOS&S Healthcare Holding Ltd. | $49.40 | -1.00% | $1.2B | — |
| 4732.TWONatureWise Biotech & Medicals Corporation | $18.00 | +0.56% | $869M | — |
| 6662.TWOBioLASCO Taiwan Co., Ltd. | $28.50 | +0.00% | $730M | — |
| 6810.TWOBio Preventive Medicine Corp. | $20.85 | +0.24% | $1.0B | — |
Source: Financial Modeling Prep · peers by sector/industry